(Q44003628)

28 November 2017

title

Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

Byung Chul Yoo

1

1 reference

28 November 2017

Joong-Won Park

2

1 reference

28 November 2017

Hyung Joon Kim

3

1 reference

28 November 2017

Dong Ho Lee

4

1 reference

28 November 2017

Young Ju Cha

5

1 reference

28 November 2017

Sill Moo Park

6

1 reference

28 November 2017

publication date

1 January 2003

1 reference

28 November 2017

published in

Journal of Hepatology

1 reference

28 November 2017

volume

38

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

98-103

1 reference

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Detection of precore hepatitis B virus mutants in asymptomatic HBsAg-positive family members

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Hepatitis B virus X gene 1751 to 1764 mutations: implications for HBeAg status and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Clinical relevance of mutations in the precore genome of the hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900349-5

7 January 2021

10.1016/S0168-8278(02)00349-5

Identifiers

DOI

1 reference

28 November 2017

1 reference